Enhanced Antitumor Activity with Combining Effect of mTOR Inhibition and Microtubule Stabilization in Hepatocellular Carcinoma
Mammalian target of rapamycin (mTOR) and the microtubules are shown to be potential targets for treating hepatocellular carcinoma (HCC). PI3K/Akt/mTOR activation is associated with resistance to microtubule inhibitors. Here, we evaluated the antitumor activity by cotargeting of the mTOR (using allos...
Saved in:
| Main Authors: | Qian Zhou, Chi Hang Wong, Cecilia Pik Yuk Lau, Connie Wun Chun Hui, Vivian Wai Yan Lui, Stephen Lam Chan, Winnie Yeo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | International Journal of Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2013/103830 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
by: Mengnan Guo, et al.
Published: (2021-01-01) -
Targeting the mTOR Pathway in Hepatocellular Carcinoma: The Therapeutic Potential of Natural Products
by: Chen G, et al.
Published: (2024-12-01) -
mTOR pathway diseases: challenges and opportunities from bench to bedside and the mTOR node
by: Laura Mantoan Ritter, et al.
Published: (2025-05-01) -
Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
by: Tanjala T. Gipson, et al.
Published: (2012-01-01) -
Pseudouridine synthase 1 promotes progression of hepatocellular carcinoma via mTOR and MYC signaling pathways
by: Li Chen, et al.
Published: (2025-03-01)